MedicalSentry

Health Research Company

SEROQUEL

generic name is Quetiapine fumarate

Why is this drug subscribed ?

Quetiapine tablets and extended-release (long-acting) tablets are used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Quetiapine tablets and extended-release tablets are also used alone or with other medications to treat episodes of mania (frenzied, abnormally excited or irritated mood) or depression in patients with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). In addition, quetiapine tablets and extended-release tablets are used with other medications to prevent episodes of mania or depression in patients with bipolar disorder. Quetiapine extended-release tablets are also used along with other medications to treat depression. Quetiapine tablets may be used as part of a treatment program to treat bipolar disorder and schizophrenia in children and teenagers. Quetiapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Active Substance: QUETIAPINE FUMARATE

SEROQUEL Available Drugs :

SEROQUEL ndc# 35356-086

by Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC

ORAL TABLET, FILM COATED with active strength of 50 mg/1

started marketing at 16/04/2012 .

SEROQUEL ndc# 54868-4961

by Physicians Total Care, Inc.

ORAL TABLET, FILM COATED with active strength of 25 mg/1

started marketing at 19/11/2003 .

SEROQUEL ndc# 55154-6918

by Cardinal Health

ORAL TABLET, FILM COATED with active strength of 200 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 55154-6920

by Cardinal Health

ORAL TABLET, FILM COATED with active strength of 300 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 55154-6909

by Cardinal Health

ORAL TABLET, FILM COATED with active strength of 25 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 55154-6910

by Cardinal Health

ORAL TABLET, FILM COATED with active strength of 100 mg/1

started marketing at 01/06/2010 .

Seroquel ndc# 35356-204

by Lake Erie Medical DBA Quality Care Products LLC

ORAL TABLET, FILM COATED with active strength of 300 mg/1

started marketing at 07/07/2010 .

Seroquel ndc# 49999-951

by Lake Erie Medical DBA Quality Care Products LLC

ORAL TABLET, FILM COATED with active strength of 200 mg/1

started marketing at 08/07/2010 .

SEROQUEL ndc# 21695-119

by Rebel Distributors Corp

ORAL TABLET, FILM COATED with active strength of 100 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 21695-118

by Rebel Distributors Corp

ORAL TABLET, FILM COATED with active strength of 50 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 21695-117

by Rebel Distributors Corp

ORAL TABLET, FILM COATED with active strength of 25 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 21695-120

by Rebel Distributors Corp

ORAL TABLET, FILM COATED with active strength of 200 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 54868-4257

by Physicians Total Care, Inc.

ORAL TABLET, FILM COATED with active strength of 100 mg/1

started marketing at 28/04/2006 .

SEROQUEL ndc# 54868-6317

by Physicians Total Care, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 50 mg/1

started marketing at 17/11/2011 .

SEROQUEL ndc# 49999-602

by Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC

ORAL TABLET, FILM COATED with active strength of 100 mg/1

started marketing at 16/04/2012 .

SEROQUEL ndc# 49999-603

by Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC

ORAL TABLET, FILM COATED with active strength of 25 mg/1

started marketing at 16/04/2012 .

SEROQUEL ndc# 54868-5581

by Physicians Total Care, Inc.

ORAL TABLET, FILM COATED with active strength of 50 mg/1

started marketing at 28/04/2006 .

SEROQUEL ndc# 16590-520

by STAT RX USA LLC

ORAL TABLET, FILM COATED with active strength of 100 mg/1

started marketing at 26/05/2011 .

SEROQUEL ndc# 54868-5484

by Physicians Total Care, Inc.

ORAL TABLET, FILM COATED with active strength of 300 mg/1

started marketing at 18/11/2011 .

SEROQUEL ndc# 16590-782

by STAT RX USA LLC

ORAL TABLET, FILM COATED with active strength of 400 mg/1

started marketing at 26/05/2011 .

SEROQUEL ndc# 55289-872

by PD-Rx Pharmaceuticals, Inc.

ORAL TABLET, FILM COATED with active strength of 25 mg/1

started marketing at 19/07/2011 .

SEROQUEL ndc# 55289-447

by PD-Rx Pharmaceuticals, Inc.

ORAL TABLET, FILM COATED with active strength of 200 mg/1

started marketing at 01/10/1997 .

SEROQUEL ndc# 55289-187

by PD-Rx Pharmaceuticals, Inc.

ORAL TABLET, FILM COATED with active strength of 100 mg/1

started marketing at 18/11/2011 .

SEROQUEL ndc# 0310-0279

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, FILM COATED with active strength of 400 mg/1

started marketing at 13/02/2006 .

SEROQUEL ndc# 0310-0278

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, FILM COATED with active strength of 50 mg/1

started marketing at 13/02/2006 .

SEROQUEL ndc# 0310-0272

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, FILM COATED with active strength of 200 mg/1

started marketing at 01/10/1997 .

SEROQUEL ndc# 0310-0275

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, FILM COATED with active strength of 25 mg/1

started marketing at 30/06/2003 .

SEROQUEL ndc# 0310-0274

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, FILM COATED with active strength of 300 mg/1

started marketing at 13/11/2000 .

SEROQUEL ndc# 0310-0271

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, FILM COATED with active strength of 100 mg/1

started marketing at 01/10/1997 .

SEROQUEL ndc# 0310-0283

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, EXTENDED RELEASE with active strength of 300 mg/1

started marketing at 16/07/2007 .

SEROQUEL ndc# 0310-0284

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, EXTENDED RELEASE with active strength of 400 mg/1

started marketing at 16/07/2007 .

SEROQUEL ndc# 0310-0280

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, EXTENDED RELEASE with active strength of 50 mg/1

started marketing at 01/02/2009 .

SEROQUEL ndc# 0310-0281

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, EXTENDED RELEASE with active strength of 150 mg/1

started marketing at 01/02/2009 .

SEROQUEL ndc# 0310-0282

by AstraZeneca Pharmaceuticals LP

ORAL TABLET, EXTENDED RELEASE with active strength of 200 mg/1

started marketing at 16/07/2007 .

SEROQUEL ndc# 67046-662

by Contract Pharmacy Services-PA

ORAL TABLET, FILM COATED with active strength of 100 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 67046-663

by Contract Pharmacy Services-PA

ORAL TABLET, FILM COATED with active strength of 200 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 67046-660

by Contract Pharmacy Services-PA

ORAL TABLET, FILM COATED with active strength of 25 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 67046-661

by Contract Pharmacy Services-PA

ORAL TABLET, FILM COATED with active strength of 50 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 67046-666

by Contract Pharmacy Services-PA

ORAL TABLET, FILM COATED with active strength of 400 mg/1

started marketing at 01/06/2010 .

SEROQUEL ndc# 67046-664

by Contract Pharmacy Services-PA

ORAL TABLET, FILM COATED with active strength of 300 mg/1

started marketing at 01/06/2010 .

Seroquel ndc# 49349-241

by REMEDYREPACK INC.

ORAL TABLET, EXTENDED RELEASE with active strength of 150 mg/1

started marketing at 23/03/2011 .

SEROQUEL Search Trends:

News :

Social Buzz

comments powered by Disqus